BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1752026)

  • 1. Variation in the isoenzymes of N-acetyl-beta-D-glucosaminidase and protein excretion in aminoglycoside nephrotoxicity in the rat.
    Sanchez-Bernal C; Vlitos M; Cabezas JA; Price RG
    Cell Biochem Funct; 1991 Jul; 9(3):209-14. PubMed ID: 1752026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of gentamicin, amikacin and dactimicin on excretion of N-acetyl-beta-D-glucosaminidase (NAG) and kidney histological pattern in rats.
    Palla R; Paternoster G; Galigani P; Giovannini L; Bertelli AA; Romano MR; Alessandrì MG; Bertelli A
    Drugs Exp Clin Res; 1987; 13(12):751-6. PubMed ID: 3447879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nephrotoxicity of the combination of cyclosporin and aminoglycoside in rats. Comparative study of gentamicin and amikacin].
    Gibey R; Mozer JL; Henry JC
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):513-6. PubMed ID: 2385448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)].
    Gibey R; Dupond JL; Peltier H; Iehl-Robert M; Henry JC
    Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
    Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F
    Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of aminoglycosides on the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes].
    Mozer JL; Gibey R; Dupond JL; Henry JC
    Pathol Biol (Paris); 1988 Mar; 36(3):230-4. PubMed ID: 3283685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of enzymuria and proteinuria: Report 1: N-acetyl-beta-glucosaminidase in urological diseases].
    Yasumoto R; Asakawa M; Yamamoto M; Doi Y; Kakinoki K; Kawashima H; Yoshimura R; Umeda M; Maekawa T
    Hinyokika Kiyo; 1987 Jun; 33(6):807-11. PubMed ID: 2445186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes by amikacin].
    Mozer JL; Gibey R; Henry JC
    C R Seances Soc Biol Fil; 1989; 183(2):166-73. PubMed ID: 2531024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possibility of determining N-acetyl-beta-D-glucosaminidase isoenzymes under alkaline conditions.
    Mandić LM; Aćimović JM; Jovanović VB
    Clin Biochem; 2005 Apr; 38(4):384-9. PubMed ID: 15766740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximal tubule damage in patients treated with gentamicin or amikacin.
    Wiland P; Szechciński J
    Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of tobramycin. Value of examining various protein and enzyme markers.
    Ylitalo P; Mörsky P; Parviainen MT; Koivula T
    Methods Find Exp Clin Pharmacol; 1991 May; 13(4):281-7. PubMed ID: 1875778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nephrotoxic potential of netilmicin as determined in a rat model.
    Luft FC
    Scand J Infect Dis Suppl; 1980; Suppl 23():82-90. PubMed ID: 6937971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demonstration of seasonal changes of circadian rhythms of amikacin chrononephrotoxicity in rats].
    Dorian C; Catroux P; Cambar J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):731-4. PubMed ID: 2889179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary phospholipids excretion in neonates treated with amikacin.
    Ibrahim S; Langhendries JP; Bernard A; Tulkens PM
    Int J Clin Pharmacol Res; 1994; 14(5-6):149-56. PubMed ID: 7672871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics].
    Gibey R; Dupond JL; Mallet H; Guerber F; Iehl-Robert M; Flausse-Parrot F; Becker M
    Nephrologie; 1986; 7(2):51-5. PubMed ID: 3736764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of dactimicin, a novel pseudo-disaccharide aminoglycoside possessing the N-formimidoyl group, compared with that of astromicin, amikacin and other aminoglycoside antibiotics in animals.
    Inouye S; Niizato T; Shomura T; Kitasato I
    Drugs Exp Clin Res; 1989; 15(5):189-209. PubMed ID: 2791871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of cyclosporine A in the rat. II. Reversible changes in intranephronal and urinary catalytic activities of N-acetyl-beta-D-glucosaminidase.
    Schmid H; Lindmeier I; Schmitt H; Eissele R; Neuhaus G; Wehrmann M
    Ren Physiol Biochem; 1993; 16(4):222-32. PubMed ID: 7689244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.